Neuland Laboratories Limited CC-Jun24.pdf · 2024-08-01
So, firstly, on the US Biosecure Act, just wanted some more clarity in terms of some of our peers have started mentioning that they are getting pilot projects or higher RFQs. So, like, are we doing anything specific to kind of gain the attention of some of these Western innovators? Or what is it that is stopping us from getting more RFQs? So, that's my first question.
Also, is it the case that the B iosecure impact is bein g felt more from a large pharma point of view right now or than some of the biotech and is that the reason why or some of the other guys are seeing more inflows or still it's broad based you think?